394 results on '"Kobayashi, Hiroya"'
Search Results
2. Protein profiling of extracellular vesicles from iPSC-derived astrocytes of patients with ALS/PDC in Kii peninsula
3. Surface smoothing of additively manufactured Ti-6Al-4V alloy by combination of grit blasting and large-area electron beam irradiation
4. Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
5. A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1
6. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy
7. Crack Width Evaluation of DFRCC Members Reinforced with Braided AFRP Bar
8. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity
9. Bond behavior simulation of deformed rebar in fiber-reinforced cementitious composites using three-dimensional meso-scale model
10. An infantile case of hereditary folate malabsorption with sudden development of pulmonary hemorrhage: a case report
11. Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.
12. Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer.
13. Synergy Effect of Abrasive Blasting and Large-area EB Irradiation on Surface Finishing of AMed Titanium Alloy
14. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery
15. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment
16. NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein.
17. Bond and Cracking Characteristics of PVA-Fiber-Reinforced Cementitious Composite Reinforced with Braided AFRP Bars
18. Severe spruelike enteropathy and collagenous colitis caused by olmesartan
19. Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
20. Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma
21. Fungal metabolite (+)-terrein suppresses IL-6/sIL-6R-induced CSF1 secretion by inhibiting JAK1 phosphorylation in human gingival fibroblasts
22. Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.
23. Facile Preparation of L-Iduronic Acid and α-L-Iduronidation Using Methyl 1,2,3,4-Tetra-O-acetyl-α-L-iduronate as Glycosyl Donor
24. Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editing
25. Supplementary Figure 4 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
26. Data from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
27. Supplementary Figure 3 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
28. Supplementary Figures from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
29. Supplementary Figure 1 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
30. Data from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
31. Supplementary Figure 2 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
32. Supplementary Figure Legends from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
33. Data from Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate–Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II–Restricted Manner
34. Supplementary Figure Legends 1-2, Methods from Induction of EBV–Latent Membrane Protein 1–Specific MHC Class II–Restricted T-Cell Responses against Natural Killer Lymphoma Cells
35. Supplementary Figures S1-S2 from Recognition of Prostate and Melanoma Tumor Cells by Six-Transmembrane Epithelial Antigen of Prostate–Specific Helper T Lymphocytes in a Human Leukocyte Antigen Class II–Restricted Manner
36. Data from Induction of EBV–Latent Membrane Protein 1–Specific MHC Class II–Restricted T-Cell Responses against Natural Killer Lymphoma Cells
37. Supplementary Figure 1 from Induction of EBV–Latent Membrane Protein 1–Specific MHC Class II–Restricted T-Cell Responses against Natural Killer Lymphoma Cells
38. Supplementary Figure 2 from Induction of EBV–Latent Membrane Protein 1–Specific MHC Class II–Restricted T-Cell Responses against Natural Killer Lymphoma Cells
39. The Fungal Metabolite (+)-Terrein Abrogates Inflammatory Bone Resorption via the Suppression of TNF-α Production in a Ligature-Induced Periodontitis Mouse Model
40. Surface finishing and change in residual stress of AMed titanium alloy by combination of grit blasting and large-area EB irradiation
41. Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
42. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
43. SARS-CoV-2 Spike Protein-Derived Immunogenic Peptides that are Promiscuously Presented by Several HLA-Class II Molecules and Their Potential for Inducing Acquired Immunity
44. Generation of a Tyrosine Hydroxylase (TH)-2A-Cre Knock-In Non-Human Primate Model by Homology Directed Repair-Biased CRISPR-Cas9 Genome Editing
45. Improvement in Mechanical Properties of AMed Al-Si Alloy Surface by Large-area EB Irradiation
46. Celecoxib promotes the efficacy of STING ‐targeted therapy by increasing antitumor CD8 + T‐cell functions via modulating glucose metabolism of CD11b + Ly6G + cells
47. Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7 ‐expressing tumor through human leukocyte antigen upregulation
48. Additional file 1 of A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1
49. Additional file 2 of A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1
50. Additional file 3 of A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.